SAMVĀD: Partners advised Eight Roads and F-Prime on its follow-on investment in Series B fundraise of Immuneel Therapeutics Pvt. Ltd.

Samvad Partners
Jun 17
1 min read

The Company operates in healthcare research, analytics and technology sector, with a focus on cancer healthcare.

The Series B round involved an aggregate capital raise of approximately INR 100 Crore, with participation from Singularity AMC, Rainmatter and Kiran Mazumdar Shaw.

The Samvad transaction team, comprised of Partners Junaira Rahman and Riddhima. P. Murjani, supported by Senior Associate Satyam Shrivas and Associates Ayush Rastogi and Shivi Shrivastava.

Recent Posts

See All

SAMVĀD: Partners acted as legal counsel to Aidin Technologies Private Limited in connection with its Series A fundraise from Indo National Limited

SAMVĀD: Partners acted as legal counsel to 12 Flags Consumer Fund Holdings in connection with its investment in the Pre-Series B fundraise of Sumosave Supermarket Technologies Private Limited

We are pleased to announce that Samvad Partners advised WEH Ventures II and WEH Ventures III on its follow-on investment series seed and series A rounds previously.

We are pleased to announce that Samvad Partners advised WEH Ventures II and WEH Ventures III (SEBI registered alternative investment funds) on its follow-on investment of approximately INR 6.9 crore i

Comments